4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-23-002023
Options or other derivatives
- Chief Business Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Linscott Walt Addison Chief Business Officer | 2023-01-18 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/ownership.xml…